Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.

Dior M, Delagrèverie H, Duboc H, Jouet P, Coffin B, Brot L, Humbert L, Trugnan G, Seksik P, Sokol H, Rainteau D, Sabate JM.

Neurogastroenterol Motil. 2016 Apr 5. doi: 10.1111/nmo.12829. [Epub ahead of print]

PMID:
27060367
2.

Editorial: mongersen in Crohn's disease - a new contribution to the beginning of a long-awaited therapeutic revolution?

Kirchgesner J, Sokol H.

Aliment Pharmacol Ther. 2016 Apr;43(7):838-9. doi: 10.1111/apt.13563. No abstract available.

PMID:
26932411
3.

Fungal microbiota dysbiosis in IBD.

Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L.

Gut. 2016 Feb 3. pii: gutjnl-2015-310746. doi: 10.1136/gutjnl-2015-310746. [Epub ahead of print]

4.

Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.

Georgin-Lavialle S, Launay JM, Côté F, Soucié E, Soria A, Damaj G, Moura DS, Canioni D, Hanssens K, Chandesris MO, Barète S, Dubreuil P, Lortholary O, Hermine O, Sokol H.

Allergy. 2016 Mar;71(3):416-20. doi: 10.1111/all.12802. Epub 2015 Dec 24.

PMID:
26841279
5.

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.

Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, Thomas M, Theodorou V, Langella P, Carvalho FA.

Sci Rep. 2016 Jan 18;6:19399. doi: 10.1038/srep19399.

6.

Toward Rational Donor Selection in Faecal Microbiota Transplantation for IBD.

Sokol H.

J Crohns Colitis. 2016 Apr;10(4):375-6. doi: 10.1093/ecco-jcc/jjw005. Epub 2016 Jan 7. No abstract available.

PMID:
26746170
7.

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.

Rossi O, van Berkel LA, Chain F, Tanweer Khan M, Taverne N, Sokol H, Duncan SH, Flint HJ, Harmsen HJ, Langella P, Samsom JN, Wells JM.

Sci Rep. 2016 Jan 4;6:18507. doi: 10.1038/srep18507.

8.

The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem.

Quévrain E, Maubert MA, Sokol H, Devreese B, Seksik P.

Gut. 2016 May;65(5):882. doi: 10.1136/gutjnl-2015-311094. Epub 2015 Dec 15. No abstract available.

PMID:
26669616
9.

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.

Liguori G, Lamas B, Richard ML, Brandi G, da Costa G, Hoffmann TW, Di Simone MP, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H.

J Crohns Colitis. 2016 Mar;10(3):296-305. doi: 10.1093/ecco-jcc/jjv209. Epub 2015 Nov 15.

PMID:
26574491
10.

Identification of novel anti-inflammatory probiotic strains isolated from pulque.

Torres-Maravilla E, Lenoir M, Mayorga-Reyes L, Allain T, Sokol H, Langella P, Sánchez-Pardo ME, Bermúdez-Humarán LG.

Appl Microbiol Biotechnol. 2016 Jan;100(1):385-396.

PMID:
26476654
11.

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, Scanzi J, Chast F, Batista R, Joly F, Joly AC, Collignon A, Guery B, Beaugerie L; French Group of Faecal microbiota Transplantation (FGFT), Alric L, Aucouturier JP, Amiot A, Barbut F, Batista R, Beaugerie L, Bemer P, Benamouzig R, Benech N, Billioud C, Boschetti G, Bourlioux P, Boubaddi N, Bouguen G, Bourreille A, Carbonnel F, Cesbron-Metivier E, Chast F, Coffin B, Collignon A, Collins M, Davido B, Davion T, Dinh A, Duboc H, Ducrotte P, Fraisse T, Gachot B, Galperine T, Guery B, Guillet M, Heyman B, Joly AC, Joly F, Kapel N, Metivier E, Mille F, Mosca A, Nebbad B, Perlemuter G, Piche T, Reimund JM, Revest M, Sabate JM, Scanzi J, Seksik P, Sobhani I, Sokol H, Schneider S, Trang C, Viennot S, Viala M, Voican C, Zerbib F.

Dig Liver Dis. 2016 Mar;48(3):242-7. doi: 10.1016/j.dld.2015.08.017. Epub 2015 Sep 7.

PMID:
26433619
12.

Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons.

Bejaoui M, Sokol H, Marteau P.

Dig Dis. 2015 Sep 14;33 Suppl 1:105-112. [Epub ahead of print]

PMID:
26366577
13.

Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.

Metghalchi S, Ponnuswamy P, Simon T, Haddad Y, Laurans L, Clément M, Dalloz M, Romain M, Esposito B, Koropoulis V, Lamas B, Paul JL, Cottin Y, Kotti S, Bruneval P, Callebert J, den Ruijter H, Launay JM, Danchin N, Sokol H, Tedgui A, Taleb S, Mallat Z.

Cell Metab. 2015 Sep 1;22(3):460-71. doi: 10.1016/j.cmet.2015.07.004. Epub 2015 Jul 30.

PMID:
26235422
14.

Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.

Hoffmann TW, Pham HP, Bridonneau C, Aubry C, Lamas B, Martin-Gallausiaux C, Moroldo M, Rainteau D, Lapaque N, Six A, Richard ML, Fargier E, Le Guern ME, Langella P, Sokol H.

ISME J. 2016 Feb;10(2):460-77. doi: 10.1038/ismej.2015.127. Epub 2015 Jul 28.

PMID:
26218241
15.

Inflammatory bowel disease after allogeneic stem cell transplantation.

Boussen I, Sokol H, Aractingi S, Georges O, Hoyeau-Idrissi N, Hugot JP, Mohty M, Rubio MT.

Bone Marrow Transplant. 2015 Oct;50(10):1365-6. doi: 10.1038/bmt.2015.138. Epub 2015 Jun 8. No abstract available.

PMID:
26052914
16.

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.

Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Chatel JM, Trugnan G, Xavier R, Langella P, Sokol H, Seksik P.

Gut. 2016 Mar;65(3):415-25. doi: 10.1136/gutjnl-2014-307649. Epub 2015 Jun 4.

PMID:
26045134
17.

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermúdez-Humarán LG, Sokol H, Thomas M, Langella P.

MBio. 2015 Apr 21;6(2). pii: e00300-15. doi: 10.1128/mBio.00300-15.

18.

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG.

BMC Microbiol. 2015 Mar 21;15:67. doi: 10.1186/s12866-015-0400-1.

19.

Changes in the Lémann Index Values During the First Years of Crohn's Disease.

Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1633-40.e3. doi: 10.1016/j.cgh.2015.02.041. Epub 2015 Mar 10.

PMID:
25766650
20.

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H.

J Crohns Colitis. 2015 Apr;9(4):349-55. doi: 10.1093/ecco-jcc/jju024. Epub 2014 Dec 28.

PMID:
25547977
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk